Duodenitis Without Bleeding Diagnosis

Diagnosis begins with symptom and medication history and then targets the likely cause. H. pylori breath or stool testing, blood work, celiac testing, stool studies, and EGD with biopsy may be used depending on persistence, severity, and alarm features.

Upper endoscopy directly visualizes the duodenum and allows biopsy, which is the most direct way to document mucosal inflammation. Laboratory and noninvasive tests help determine why the inflammation is present rather than merely confirming that it exists.

Not every patient needs EGD. It becomes more useful when symptoms persist, alarm features are present, noninvasive testing does not explain the problem, ulcer disease is suspected, or tissue biopsy is needed for celiac disease or another microscopic disorder.

Biopsy may show acute or chronic inflammatory changes, villous injury, increased intraepithelial lymphocytes, eosinophilia, erosive injury, infection-related changes, or other patterns. The findings must be interpreted with symptoms, serology, medicines, and endoscopic appearance.

They combine symptom timing, NSAID and medication exposure, H. pylori testing, alcohol and smoking history, endoscopy, biopsy, celiac testing, infection risk, and evidence of Crohn disease or other inflammatory conditions.

Active infection is usually assessed with a urea breath test or stool antigen test, or biopsy-based testing when EGD is performed. Medicines such as proton pump inhibitors, antibiotics, and bismuth can affect test accuracy, so preparation should follow clinician instructions.

The diagnosis is based on a compatible medication history plus the absence or treatment of competing causes such as H. pylori. Endoscopy may show inflammation, erosions, or ulcers, but there is no single biopsy finding that proves NSAID injury by itself.

Treatment is cause-specific. Options may include H. pylori eradication, acid suppression, coordinated changes to NSAID exposure, treatment of celiac or Crohn disease, infection therapy, and removal of aggravating factors such as smoking or heavy alcohol use.

Proton pump inhibitors are commonly used for acid-related inflammation or ulcer healing. Confirmed H. pylori requires combination eradication therapy rather than acid suppression alone. Other medicines depend on whether an inflammatory, infectious, or immune disorder is present.

Duration depends on the cause. H. pylori eradication regimens are commonly given for 14 days under current guideline-based treatment, while acid-healing therapy may continue longer. Persistent symptoms should prompt reassessment rather than indefinite self-treatment.

Avoid foods or drinks that consistently worsen symptoms and limit heavy alcohol use. A restrictive diet should not replace diagnosis. Gluten avoidance is appropriate for confirmed celiac disease, not simply because duodenitis is present.

The care plan rechecks the original diagnosis, adherence, H. pylori eradication, NSAID exposure, biopsy quality, celiac testing, and alternative causes such as Crohn disease or functional dyspepsia. Repeat EGD is considered when it is likely to change management.

Depending on the cause, ongoing inflammation may progress to duodenal ulceration, bleeding, iron deficiency, dehydration from vomiting or diarrhea, or persistent nutrient problems. Severe symptoms may indicate another condition that needs urgent evaluation.

Follow-up should confirm that the cause was addressed and symptoms improved. H. pylori requires a test-of-cure after treatment. Repeat laboratory testing or endoscopy is individualized based on ulceration, persistent symptoms, anemia, or biopsy abnormalities.

GI evaluation is appropriate for persistent or recurrent upper abdominal pain, nausea, vomiting, bloating, appetite change, unexplained diarrhea, anemia, weight loss, or an abnormal endoscopy. Black stool, vomiting blood, fainting, or severe pain requires urgent care.